In the T47D breast cancer cell line, Skildum et al. demonstrated that the mutant form of the PR-B (S294A PR-B) with low transcriptional activity and diminished proteasomal degradation [40] could activate the Ras/Raf/MAPK cascade in a ligand-dependent manner. This evidence concerns the gene RB1 and breast cancer.